199 related articles for article (PubMed ID: 2441738)
1. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
2. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
[TBL] [Abstract][Full Text] [Related]
3. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
[TBL] [Abstract][Full Text] [Related]
5. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
8. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
9. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
[TBL] [Abstract][Full Text] [Related]
11. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
Kato T; Nishimura H; Hamai J; Yamabe T; Nakajima H; Nakano T; Noda K; Teshima K; Suzuki H; Ueda G
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2338-45. PubMed ID: 3007640
[No Abstract] [Full Text] [Related]
14. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
15. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
[TBL] [Abstract][Full Text] [Related]
16. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
17. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
Heald J; Buckley CH; Fox H
J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
[TBL] [Abstract][Full Text] [Related]
19. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
[TBL] [Abstract][Full Text] [Related]
20. CA-125 in patients with endometriosis.
Barbieri RL
Fertil Steril; 1986 Jun; 45(6):767-9. PubMed ID: 2423377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
